SAFETYLIT WEEKLY UPDATE

We compile citations and summaries of about 400 new articles every week.
RSS Feed

HELP: Tutorials | FAQ
CONTACT US: Contact info

Search Results

Journal Article

Citation

Schmidt EM, Gupta S, Bowe T, Ellerbe LS, Phelps TE, Finney JW, Asch SM, Humphreys K, Trafton J, Vanneman M, Harris AH. Subst. Abuse 2016; 38(3): 317-323.

Affiliation

Center for Innovation to Implementation (Ci2i), Veterans Affairs Palo Alto Health Care System , Menlo Park , California , USA.

Copyright

(Copyright © 2016, Informa - Taylor and Francis Group)

DOI

10.1080/08897077.2016.1212779

PMID

27435754

Abstract

BACKGROUND: Measures of substance use disorder (SUD) treatment quality are essential tools for performance improvement. The Veterans Health Administration (VHA) developed a measure of access to and engagement in intensive outpatient programs (IOP) for SUD. However, predictive validity, or associations between this measure and treatment outcomes, has not been examined.

METHODS: Data on veterans with SUD came from three samples: the Outcomes Monitoring Project (N = 5,436), a national evaluation of VHA mental health services (N = 339,887), and patients receiving detoxification services (N = 23,572). Propensity score-weighted mixed-effects regressions modeled associations between receiving at least one week of IOP treatment and patient outcomes, controlling for facility-level performance and a random effect for facility.

RESULTS: Propensity-score weighting reduced or eliminated observable baseline differences between patient groups. Patients who accessed IOP versus those who did not reported significantly reduced alcohol- and drug-related symptom severity, with significantly fewer past-month days drinking alcohol (b = 1.83, p <.001) and fewer past-month days intoxicated (b = 1.55, p <.001). Patients who received IOP after detoxification services had higher 6-month utilization of SUD outpatient visits (b = 2.09, p <.001), more subsequent detoxification episodes (b = 0.25, p <.001), and lower odds of 2-year mortality (OR = 0.68, 95% CI 0.61 - 0.75, p <.001).

CONCLUSIONS: Receiving at least one week of SUD treatment in an IOP was associated with higher follow-up utilization, improved health outcomes, and reduced mortality. These associations lend support to the predictive validity of VHA's IOP quality measure. Future research should focus on measure feasibility and validity outside of VHA, and whether predictive validity is maintained once this quality measure is tied to performance incentives.


Language: en

NEW SEARCH


All SafetyLit records are available for automatic download to Zotero & Mendeley
Print